Atlas Arteria Valuation Multiples

Atlas Arteria is valued at $3.8B as of November 2026, a 37.4x revenue multiple. In the last 12 months, Atlas Arteria revenue was $126M and Atlas Arteria EBITDA was $31M.

Atlas Arteria Overview

About Atlas Arteria

Atlas Arteria is a global toll-road investor created out of the reorganization of Macquarie Infrastructure Group in 2010. The firm's main asset is a 30.82% stake in Autoroutes Paris-Rhin-Rhone, or APRR. APRR owns concessions to toll more than 2,300 kilometers of motorways in eastern France, most ending late 2035. The firm also wholly owns the Dulles Greenway and 66.67% of the Chicago Skyway, both in the US.


Founded

2009

HQ

Australia

Employees

3.3K

Financials (LTM)

Revenue: $126M
EBITDA: $31M

EV

$4.7B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Atlas Arteria Financials

Atlas Arteria reported last 12-month revenue of $126M and EBITDA of $31M.

In the same LTM period, Atlas Arteria generated $31M in EBITDA and $174M in net income.

Revenue (LTM)


Atlas Arteria P&L

In the most recent fiscal year, Atlas Arteria reported revenue of $110M and EBITDA of $40M.

Atlas Arteria is profitable as of last fiscal year, with gross margin of 86%, EBITDA margin of 36%, and net margin of 163%.

See analyst estimates for Atlas Arteria
LTMLast FY202320242025202620272028
Revenue$126M$110M$96M$104M$110M
Gross Profit-$95M$88M$100M$95M
Gross Margin-86%92%96%86%
EBITDA$31M$40M--$40M
EBITDA Margin24%36%--36%
EBIT Margin(50%)(15%)(4%)(6%)(15%)
Net Profit$174M$180M$232M$241M$180M
Net Margin138%163%243%232%163%
Net Debt-$997M---

Financial data powered by Morningstar, Inc.

Atlas Arteria Stock Performance

Atlas Arteria has current market cap of $3.8B, and enterprise value of $4.7B.

Market Cap Evolution


Atlas Arteria's stock price is $2.60.

Atlas Arteria share price decreased by 0.3% in the last 30 days, and by 20.0% in the last year.

Atlas Arteria has an EPS (earnings per share) of $0.12.

See more trading valuation data for Atlas Arteria
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$4.7B$3.8B-0.1%-0.3%-21.0%-20.0%$0.12

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Atlas Arteria Valuation Multiples

Atlas Arteria trades at 37.4x EV/Revenue multiple, and 154.5x EV/EBITDA.

See NTM and 2027E valuation multiples for Atlas Arteria

EV / Revenue (LTM)


Atlas Arteria Financial Valuation Multiples

As of November 8, 2026, Atlas Arteria has market cap of $3.8B and EV of $4.7B.

Atlas Arteria has a P/E ratio of 21.7x.

LTMLast FY202320242025202620272028
EV/Revenue37.4x42.9x49.4x45.4x42.9x
EV/EBITDA154.5x117.9x--117.9x
EV/EBIT(75.0x)n/mn/mn/mn/m
EV/Gross Profit-49.8x53.6x47.5x49.8x
P/E21.7x21.0x16.3x15.7x21.0x
EV/FCF13.0x86.8x88.0x79.6x86.8x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Atlas Arteria Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Atlas Arteria Margins & Growth Rates

Atlas Arteria grew revenue by 17% but EBITDA decreased by 28% in the last fiscal year.

In the most recent fiscal year, Atlas Arteria reported gross margin of 86%, EBITDA margin of 36%, and net margin of 163%.

See estimated margins and future growth rates for Atlas Arteria

Atlas Arteria Margins

Last FY202420252026202720282029
Gross Margin86%96%86%34%
EBITDA Margin36%-36%23%
EBIT Margin(15%)(6%)(15%)(56%)
Net Margin163%232%163%142%
FCF Margin49%57%49%279%

Atlas Arteria Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth17%9%6%17%
Gross Profit Growth(54%)13%(5%)(54%)
EBITDA Growth(28%)--(28%)
EBIT Growth342%37%179%342%
Net Profit Growth1%4%(25%)1%
FCF Growth560%11%(8%)560%

Data powered by FactSet, Inc. and Morningstar, Inc.

Atlas Arteria Operational KPIs

Atlas Arteria's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.0M for the same period.

Atlas Arteria's Rule of 40 is 39% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Atlas Arteria's Rule of X is 64% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Atlas Arteria
LTMLast FY202320242025202620272028
Rule of 4016%39%---
Bessemer Rule of X3%64%---
Revenue per Employee-$0.0M---
Opex per Employee-$0.0M---
G&A Expenses to Revenue-25%25%24%25%
Opex to Revenue-101%97%101%101%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Atlas Arteria Competitors

Atlas Arteria competitors include Infraestrctura Visble, Guangdong Expressway, Primoris Services, Anhui Expressway, Ventia, Construction Partners, Shenzhen Expressway Corp, Hill & Smith, Elecnor and Zhejiang Expressway.

Most Atlas Arteria public comparables operate across Road Infrastructure.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Infraestrctura Visble$390M-9.7x---
Guangdong Expressway$671M$640M8.0x8.1x8.4x9.8x
Primoris Services$7.6B$505M0.6x0.6x8.9x13.7x
Anhui Expressway$1B$629M6.1x5.8x9.7x9.3x
Ventia$4.3B$386M0.9x0.9x9.7x9.5x
Construction Partners$2.8B$373M2.2x1.7x16.6x11.4x
Shenzhen Expressway Corp$1.4B$735M5.6x4.8x10.6x10.3x
Hill & Smith$1.1B$213M2.7x2.5x14.3x11.7x

This data is available for Pro users. Sign up to see all Atlas Arteria competitors and their valuation data.

Start Free Trial

Atlas Arteria VC Funding History

Before going public, Atlas Arteria raised funding across 1 round.


Atlas Arteria Funding Rounds

DateStageInvestorsRaisedValuationRev. MultipleDeal Summary
Mar-22SecondaryIFM Investors--The IFM Global Infrastructure Fund began building a stake in the ASX-listed toll road owner Atlas Arteria in March 2022, acquiring shares on market. By June 2022 the holding had reached about 15 per cent, and IFM subsequently increased it further. Atlas Arteria owns, operates and develops toll roads, with interests in France, Germany and the United States, including the APRR network in France, the Warnow Tunnel in Germany and the Chicago Skyway. In September 2022 IFM made a non-binding proposal valued at about AUD 7 billion for the shares it did not already own, which did not proceed to a transaction. IFM has continued to add to the position in later years.

Acquisitions by Atlas Arteria

Atlas Arteria has acquired 1 company to date.

Last acquisition by Atlas Arteria was on September 14th 2022. Atlas Arteria acquired Chicago Skyway for $3B (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by Atlas Arteria

Chicago Skyway
Description
Chicago Skyway is a Chicago-operated toll road spanning 7.8 miles from the Dan Ryan Expressway to the Indiana Toll Road. Opened in 1958, its main bridge over the Calumet River offers 125 feet of vertical clearance for industrial shipping. The facility handles heavy truck traffic and collects electronic tolls.
HQ CountryUnited States
HQ City
Chicago, IL
Deal Date14 Sep 2022
Valuation$3B
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Atlas Arteria acquisitions and their M&A valuation multiples.

Start Free Trial

Investments by Atlas Arteria

Atlas Arteria has invested in 1 company to date.

Latest investment by Atlas Arteria was on November 20th 2019. Atlas Arteria invested in APRR in their Secondary round.

See VC round multiples

Latest Investments by Atlas Arteria

APRR
Description
Autoroutes Paris-Rhin-Rhone (APRR) operates France's second-largest and Europe's fourth-largest toll motorway network, running concessions across eastern and central France. It earns toll revenue under long-term state concessions and has invested heavily in widening, environmental works and free-flow electronic tolling. It is held through the Eiffarie holding structure by Eiffage alongside institutional investors.
HQ CountryFrance
HQ City
Saint-Apollinaire
Deal Date20 Nov 2019
RoundSecondary
Raisedundisclosed
InvestorsAtlas Arteria
Valuation$954M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Atlas Arteria investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Atlas Arteria

When was Atlas Arteria founded?Atlas Arteria was founded in 2009.
Where is Atlas Arteria headquartered?Atlas Arteria is headquartered in Australia.
How many employees does Atlas Arteria have?As of today, Atlas Arteria has over 3K employees.
Who is the CEO of Atlas Arteria?Atlas Arteria's CEO is Hugh Wehby.
Is Atlas Arteria publicly listed?Yes, Atlas Arteria is a public company listed on Australian Securities Exchange.
What is the stock symbol of Atlas Arteria?Atlas Arteria trades under ALX ticker.
When did Atlas Arteria go public?Atlas Arteria went public in 2010.
Who are competitors of Atlas Arteria?Atlas Arteria main competitors include Infraestrctura Visble, Guangdong Expressway, Primoris Services, Anhui Expressway, Ventia, Construction Partners, Shenzhen Expressway Corp, Hill & Smith, Elecnor, Zhejiang Expressway.
What is the current market cap of Atlas Arteria?Atlas Arteria's current market cap is $3.8B.
What is the current revenue of Atlas Arteria?Atlas Arteria's last 12 months revenue is $126M.
What is the current revenue growth of Atlas Arteria?Atlas Arteria revenue growth (NTM/LTM) is (9%).
What is the current EV/Revenue multiple of Atlas Arteria?Current revenue multiple of Atlas Arteria is 37.4x.
What is the current EBITDA of Atlas Arteria?Atlas Arteria's last 12 months EBITDA is $31M.
What is Atlas Arteria's EBITDA margin?Atlas Arteria's last 12 months EBITDA margin is 24%.
What is the current EV/EBITDA multiple of Atlas Arteria?Current EBITDA multiple of Atlas Arteria is 154.5x.
What is the current FCF of Atlas Arteria?Atlas Arteria's last 12 months FCF is $363M.
What is Atlas Arteria's FCF margin?Atlas Arteria's last 12 months FCF margin is 287%.
What is the current EV/FCF multiple of Atlas Arteria?Current FCF multiple of Atlas Arteria is 13.0x.
How many companies Atlas Arteria has acquired to date?As of November 2026, Atlas Arteria has acquired 1 company.
What was the largest acquisition by Atlas Arteria?$3B acquisition of Chicago Skyway on 14th September 2022 was the largest M&A Atlas Arteria has done to date.
What companies Atlas Arteria acquired?Atlas Arteria acquired Chicago Skyway.
In how many companies Atlas Arteria has invested to date?As of November 2026, Atlas Arteria has invested in 1 company.
What was the last Atlas Arteria investment?On 20th November 2019 Atlas Arteria invested in APRR, participating in a Secondary round at $954M valuation.
In what companies Atlas Arteria invested in?Atlas Arteria invested in APRR.

See public comps similar to Atlas Arteria

Lists including Atlas Arteria

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial